Guggenheim Capital’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-58,798
| Closed | -$4.99M | – | 2095 |
|
|
2019
Q4 | $4.99M | Buy |
58,798
+3,746
| +7% | +$250K | 0.04% | 630 |
|
|
2019
Q3 | $2.75M | Sell |
55,052
-26,588
| -33% | -$1.06M | 0.02% | 877 |
|
|
2019
Q2 | $2.98M | Sell |
81,640
-1,234
| -1% | -$40.3K | 0.02% | 871 |
|
|
2019
Q1 | $2.32M | Sell |
82,874
-5,533
| -6% | -$130K | 0.02% | 1006 |
|
|
2018
Q4 | $1.69M | Sell |
88,407
-1,522
| -2% | -$35.4K | 0.01% | 1127 |
|
|
2018
Q3 | $2.69M | Buy |
89,929
+4,427
| +5% | +$167K | 0.02% | 1070 |
|
|
2018
Q2 | $3.14M | Sell |
85,502
-3,961
| -4% | -$129K | 0.02% | 985 |
|
|
2018
Q1 | $2.95M | Sell |
89,463
-10,961
| -11% | -$343K | 0.01% | 1365 |
|
|
2017
Q4 | $2.74M | Sell |
100,424
-23,318
| -19% | -$718K | 0.01% | 1435 |
|
|
2017
Q3 | $4.58M | Buy |
123,742
+27,379
| +28% | +$1.01M | 0.01% | 1120 |
|
|
2017
Q2 | $3.66M | Buy |
96,363
+19,171
| +25% | +$854K | 0.01% | 1200 |
|
|
2017
Q1 | $3.78M | Sell |
77,192
-4,942
| -6% | -$225K | 0.01% | 1192 |
|
|
2016
Q4 | $2.79M | Sell |
82,134
-17,380
| -17% | -$616K | 0.01% | 1423 |
|
|
2016
Q3 | $3.76M | Sell |
99,514
-4,880
| -5% | -$184K | 0.01% | 1192 |
|
|
2016
Q2 | $3.51M | Sell |
104,394
-7,261
| -7% | -$256K | 0.01% | 1196 |
|
|
2016
Q1 | $3.55M | Sell |
111,655
-46,530
| -29% | -$1.52M | 0.01% | 1184 |
|
|
2015
Q4 | $5.91M | Sell |
158,185
-38,118
| -19% | -$1.44M | 0.02% | 943 |
|
|
2015
Q3 | $7.45M | Sell |
196,303
-73,925
| -27% | -$2.59M | 0.02% | 867 |
|
|
2015
Q2 | $7.73M | Buy |
270,228
+38,811
| +17% | +$1.08M | 0.02% | 956 |
|
|
2015
Q1 | $6.48M | Buy |
231,417
+74,525
| +48% | +$2.09M | 0.02% | 1044 |
|
|
2014
Q4 | $4.34M | Sell |
156,892
-24,757
| -14% | -$613K | 0.01% | 1191 |
|
|
2014
Q3 | $4.05M | Buy |
181,649
+11,203
| +7% | +$285K | 0.01% | 1318 |
|
|
2014
Q2 | $4.95M | Sell |
170,446
-35,959
| -17% | -$960K | 0.01% | 1192 |
|
|
2014
Q1 | $5.87M | Buy |
206,405
+32,321
| +19% | +$1.07M | 0.02% | 1046 |
|
|
2013
Q4 | $6.72M | Sell |
174,084
-8,568
| -5% | -$306K | 0.02% | 969 |
|
|
2013
Q3 | $6.12M | Buy |
182,652
+47,229
| +35% | +$1.5M | 0.02% | 1005 |
|
|
2013
Q2 | $4.17M | Buy |
+135,423
| New | +$4.53M | 0.02% | 1140 |
|
Other funds holding MDCO
Guggenheim Capital's MDCO Position: Q1 2020 in Review
Guggenheim Capital sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 58,798 shares — an estimated $4.99M sold.
Guggenheim Capital first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $7.73M in Q2 2015. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Guggenheim Capital reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Guggenheim Capital sold 58,798 Medicines Co shares in Q1 2020, an estimated $4.99M.
- Guggenheim Capital first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Guggenheim Capital's Medicines Co position peaked at $7.73M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Guggenheim Capital's 13F filing for Q1 2020, filed 2 Jun 2020.